Rebecca Heist's guest appearances

Rebecca Heist

Lung Cancer Considered

Oncology Today with Dr Neil Love

The Research Evangelist

OwlTail

What are Antibody Drug Conjugates, and do they have a promising future in lung cancer treatment? To discuss this topic, Lung Cancer Considered host Dr. Stephen Liu is joined by Dr. Rebecca Heist, associate director of clinical research at Massachusetts General Hospital Cancer Center in Boston, and Dr. Ben Levy, clinical director of medical oncology at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center in Baltimore.

Antibody Drug Conjugates (ADC) with Ben Levy And Rebecca Heist

On today's episode meet Rebecca Heist, MD, MPH, a Medical Oncologist at Massachusetts General Hospital and Associate Professor of Medicine, Harvard Medical School. Her research focuses on clinical trials of novel agents. As part of the Termeer Center at MGH, she leads first-in-human studies of targeted agents across a broad range of tumor types, with a particular focus in lung. Her commitment to her patients is very clear.

<p>On today's episode meet Rebecca Heist, MD, MPH, a Medical Oncologist at Massachusetts General Hospital and Associate Professor of Medicine, Harvard Medical School. Her research focuses on clinical trials of novel agents. As part of the Termeer Center at MGH, she leads first-in-human studies of targeted agents across a broad range of tumor types, with a particular focus in lung. Her commitment to her patients is very clear.</p>